Sarah Cannon Research Institute
Matthew Weaver has extensive experience in regulatory operations and management within the clinical research domain, currently serving as Manager of Site Regulatory Operations at Sarah Cannon Research Institute since January 2020. Prior roles include Senior Site Regulatory Specialist and Site Regulatory Specialist at the same institute. Before joining Sarah Cannon, Matthew worked at Bob Weaver CPA as an Account Manager and held the position of Biomedical Research Assistant at The University of Memphis. Matthew obtained a Bachelor of Science degree from Middle Tennessee State University between 2017 and 2019.
This person is not in the org chart
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.